STOCK TITAN

Proposed Class A sale by DNA (NYSE: DNA) — Form 144 lists 40,893 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

DNA filed a Form 144 reporting a proposed sale of Class A shares and recent small dispositions. The filing lists 40,893 Class A shares tied to a proposed sale and records two past dispositions of 2,200 shares on 02/04/2026 and 03/11/2026. The broker listed is Fidelity Brokerage Services LLC.

Positive

  • None.

Negative

  • None.
Proposed shares to be sold 40,893 shares listed in the filing excerpt
Disposition on 02/04/2026 2,200 shares past sale recorded for Austin Che on 02/04/2026
Disposition on 03/11/2026 2,200 shares past sale recorded for Austin Che on 03/11/2026
Broker Fidelity Brokerage Services LLC broker listed with address 900 Salem Street, Smithfield RI
Dollar amount shown (02/04/2026) $19,360 amount listed next to 02/04/2026 disposition in excerpt
Dollar amount shown (03/11/2026) $13,882 amount listed next to 03/11/2026 disposition in excerpt
Form 144 regulatory
"Class A | Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Restricted Stock Vesting financial
"Class A | 04/10/2026 | Restricted Stock Vesting"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
Securities To Be Sold regulatory
"144: Securities To Be Sold"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does DNA's Form 144 report about proposed sales?

It reports a proposed sale of 40,893 Class A shares. The filing shows the broker as Fidelity Brokerage Services LLC and an effective/filing date of 04/13/2026 in the excerpt.

Who acted as broker for the transactions in DNA's Form 144?

Fidelity Brokerage Services LLC is listed as the broker. The filing gives an address for Fidelity at 900 Salem Street, Smithfield, RI, tied to the reported transactions.

What recent dispositions are disclosed in the DNA excerpt?

Two past dispositions of 2,200 Class A shares each are disclosed on 02/04/2026 and 03/11/2026. The entries include dollar amounts associated with those sales in the excerpt.

Does the Form 144 excerpt identify the selling party?

Yes; the excerpt names Austin Che with an address at 27 Drydock Avenue, 8th Floor, Boston, MA. That name appears alongside the two recent 2,200-share dispositions.